title: Missed appointments at a tuberculosis clinic increased the risk of clinical treatment failure.
abstract: We investigated the charts of 381 new smear-positive tuberculosis patients at Khon Kaen Medical School during 1997-2001 using World Health Organization definitions to evaluate associations among treatment success or failure (defaulted, failed, died, or not evaluated) and tuberculosis clinic contact, demographics and clinical characteristics of the patients. Multinomial logistic regression was used for three-category outcome analysis: treatment success, transferred-out and clinical treatment failure. The treatment success and clinical treatment failure rates were 34.1% and 34.4%, respectively. About 46.5% and 85.8% of patients missed appointments at the tuberculosis clinic in the treatment success and treatment failure groups, respectively. The results show that patients who were absent from the tuberculosis clinic were 5.95 times more likely to have clinical treatment failure than treatment success, having adjusted for the effect of transfering-out and the effect of the treatment regimen and the sputum conversion status (adjusted odds ratio = 5.95; 95% CI: 2.99 to 11.84). The review showed that absence from the tuberculosis clinic was an independent risk factor for clinical treatment failure. We recommended that all new smear-positive tuberculosis patients should be followed closely at a tuberculosis clinic.
authors.affiliation: Faculty of Medicine, Khon Kaen University, Khon Kaeny, Thailand. sompong@kku.ac.th
authors.forename: Sompong
authors.initials: S
authors.lastname: Srisaenpang
authors.forename: Somdej
authors.initials: S
authors.lastname: Pinitsoontorn
authors.forename: Pratap
authors.initials: P
authors.lastname: Singhasivanon
authors.forename: Dwip
authors.initials: D
authors.lastname: Kitayaporn
authors.forename: Jaranit
authors.initials: J
authors.lastname: Kaewkungwal
authors.forename: Pyatat
authors.initials: P
authors.lastname: Tatsanavivat
authors.forename: Boonsong
authors.initials: B
authors.lastname: Patjanasoontorn
authors.forename: Wipa
authors.initials: W
authors.lastname: Reechaipichitkul
authors.forename: Jammari
authors.initials: J
authors.lastname: Thiratakulpisan
authors.forename: Jiraporn
authors.initials: J
authors.lastname: Srinakarin
authors.forename: Prasopsuk
authors.initials: P
authors.lastname: Srisaenpang
authors.forename: Bandit
authors.initials: B
authors.lastname: Thinkamrop
authors.forename: Chalermchai
authors.initials: C
authors.lastname: Apinyanurak
authors.forename: Bung-onsee
authors.initials: BO
authors.lastname: Chindawong
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016001:Confidence Intervals; D005260:Female; D006801:Humans; D016013:Likelihood Functions; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010349:Patient Compliance; D012189:Retrospective Studies; D012307:Risk Factors; D017211:Treatment Failure; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000995:Antitubercular Agents